Group 1 - The State Intellectual Property Office of China has granted a patent for a method of preparing L96 side-chain compounds to Suzhou Fushilai Pharmaceutical Co., Ltd. and Suzhou Kuntai Biotechnology Co., Ltd., with the patent announcement number CN118993970B and application date of May 2023 [1] - Suzhou Fushilai Pharmaceutical Co., Ltd. was established in 2000, located in Suzhou, and primarily engages in the manufacturing of chemical raw materials and products, with a registered capital of 91.67 million RMB [1] - Suzhou Fushilai has invested in 4 companies, participated in 57 bidding projects, holds 20 trademark registrations, 108 patents, and possesses 82 administrative licenses [1] - Suzhou Kuntai Biotechnology Co., Ltd. was founded in 2022, also located in Suzhou, focusing on research and experimental development, with a registered capital of 50 million RMB [1] - Suzhou Kuntai has participated in 6 bidding projects, holds 4 patents, and has 4 administrative licenses [1]
富士莱医药取得L96侧链化合物制备方法专利